Schrodinger, Inc. (SDGR) Dividend History

Company News

• AI Healthcare Boom Gains Speed as Regulators and Innovators Align

  The integration of artificial intelligence (AI) into healthcare is accelerating, with 90% of healthcare companies already seeing positive ROI from investments in generative AI. Several companies, including Avant Technologies, Tempus AI, Tevogen Bio Holdings, GE HealthCare Technologies, and Schrödinger, are making advancements in AI-driven healthcare solutions.

  Benzinga

  Featured Companies: GEHC TEM TVGN
• 3 Momentum Stocks That Could Soar Post-Market Volatility

  Three companies in the software-based drug development and furniture industries have emerged as momentum plays following a period of market volatility. Certara, Schrodinger, and Lovesac have seen their stock prices rise significantly due to positive news, technological advancements, and adaptable business models.

  Investing.com

  Featured Companies: CERT LOVE
• Biosimulation Industry Forecast, 2029: Analysis of Case Studies, Market Dynamics, Regional Growth Trends, Regulatory Landscape, Value Chain, and Competitive Intelligence

  The biosimulation market is projected to reach USD 9.18 billion by 2029, growing at a CAGR of 16.7% from 2024 to 2029. The market is driven by the increasing need for cost and time reduction in the drug development process, but high costs of biosimulation technologies remain a restraint.

  GlobeNewswire Inc.

  Featured Companies: ANSS CERT SLP
• Material Informatics Market Share is Growing at 16.4% CAGR to Hit USD 705.21 million by 2034 | PMR

  The global material informatics market is expected to grow at a CAGR of 16.4% from 2025 to 2034, driven by the increasing demand for advanced materials in sectors like aerospace, electronics, and energy.

  GlobeNewswire Inc.
• Schrödinger Scores Big Despite Q3 Miss As Novartis Collaboration Promises Billions In Milestones: Details

  Schrödinger partners with Novartis for advanced computational drug discovery, with Schrödinger receiving $150 million upfront and eligible for up to $2.3 billion in milestone payments. Despite a Q3 revenue miss, Schrödinger revised its 2024 software guidance upwards.

  Benzinga